← Company intelligence

Robot maker · early

LivsMed

Corporate marketmedicalCurated record

Korean surgical-device maker commercializing ArtiSential articulating laparoscopic instruments since 2018 and now building the STARK laparoscopic surgical robot. STARK's telesurgery capability was demonstrated in a July 2025 wet-lab feasibility study with Sovato (console in Santa Barbara operating a system in Chicago); animal trials began May 2026 with MFDS approval filing planned within the year and a dedicated robot factory slated for late 2027. Completed the largest KOSDAQ IPO of the 2025 cycle in January 2026 to fund robotic and US expansion.

HeadquartersSeongnam, KR
Founded2011
Corporate funding$94M
TeamNot listed
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StagePublic (KOSDAQ IPO Jan 2026, ~$94M raised, ~$1B market cap)
FoundersJung Joo Lee (Founder & CEO)
Regions servedAsia, North America, Europe
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
LinkedInNot listed
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

STARK surgical robot

  • Laparoscopic surgical robot with telesurgery capability; remote wet-lab surgery demonstrated with surgeon console in Santa Barbara, CA and robot in Chicago, IL via Sovato platform (July 2025)

    early-feasibility remote-surgery demonstration of the robot system

    Claim source
CA

Funding history

Publicly announced rounds

TL

Company timeline

Milestones and announcements

2026-01-15Completed largest KOSDAQ IPO of the cycle, raising ~$94M (W135.9B) at ~$1B market cap to accelerate robotic surgery and US expansionBusiness Wire
2025-07-14Unveiled STARK robotic system with telesurgery capabilities in partnership with SovatoBusiness Wire
SC

Source ledger

2 unique public sources